Clinical Trial Update: Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

View source ↗

Summary

A completed post-marketing study of apixaban (ELIQUIS) in Mexico investigating treatment in patients with deep vein thrombosis and pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Deep Vein Thrombosis, Pulmonary Embolism | Status: COMPLETED